Arcellx, Inc. (ACLX)
Arcellx Market Cap : 6.715B for April 10, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 172.55B |
| Eli Lilly & Co. | 839.28B |
| Merck & Co., Inc. | 300.20B |
| Bristol Myers Squibb Co. | 119.38B |
| BioMarin Pharmaceutical, Inc. | 10.49B |
Market Cap Related Metrics
| PS Ratio | 291.09 |
| PEG Ratio | -0.2736 |
| Price to Book Value | 16.69 |
| Price | 114.83 |
| Earnings Yield | -3.53% |
| PEGY Ratio | -0.2736 |